PWM
CVS icon

Perigon Wealth Management’s CVS Health CVS Stock Holding History

Perigon Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.37M Sell
32,994
-894
-3% -$68.9K 0.04% 340
2025
Q4 		$2.69M Buy
33,888
+35
+0.1% +$2.76K 0.05% 307
2025
Q3 		$2.55M Buy
33,853
+18,872
+126% +$1.29M 0.05% 301
2025
Q2 		$1.03M Sell
14,981
-179
-1% -$11.7K 0.02% 460
2025
Q1 		$1.03M Sell
15,160
-4,822
-24% -$289K 0.03% 447
2024
Q4 		$1.04M Sell
19,982
-309
-2% -$17.3K 0.03% 437
2024
Q3 		$1.28M Sell
20,291
-3,117
-13% -$182K 0.03% 373
2024
Q2 		$1.38M Sell
23,408
-6,191
-21% -$387K 0.04% 303
2024
Q1 		$2.36M Sell
29,599
-2,240
-7% -$171K 0.07% 230
2023
Q4 		$2.51M Buy
31,839
+3,937
+14% +$280K 0.08% 201
2023
Q3 		$1.95M Sell
27,902
-7,189
-20% -$509K 0.08% 209
2023
Q2 		$2.43M Sell
35,091
-1,380
-4% -$98.2K 0.1% 191
2023
Q1 		$2.71M Sell
36,471
-285
-0.8% -$23.9K 0.15% 137
2022
Q4 		$3.43M Buy
36,756
+15,725
+75% +$1.52M 0.21% 111
2022
Q3 		$2.01M Buy
21,031
+332
+2% +$32.9K 0.17% 123
2022
Q2 		$1.92M Buy
20,699
+863
+4% +$84.2K 0.16% 130
2022
Q1 		$2.01M Buy
19,836
+314
+2% +$33K 0.14% 134
2021
Q4 		$2.01M Buy
19,522
+1,437
+8% +$133K 0.14% 136
2021
Q3 		$1.53M Buy
18,085
+352
+2% +$29.5K 0.13% 143
2021
Q2 		$1.48M Buy
17,733
+294
+2% +$24.1K 0.13% 142
2021
Q1 		$1.31M Buy
17,439
+61
+0.4% +$4.44K 0.13% 147
2020
Q4 		$1.19M Sell
17,378
-4,259
-20% -$277K 0.14% 125
2020
Q3 		$1.26M Sell
21,637
-1,779
-8% -$111K 0.18% 99
2020
Q2 		$1.52M Sell
23,416
-29
-0.1% -$1.83K 0.24% 77
2020
Q1 		$1.42M Buy
23,445
+1,287
+6% +$85.9K 0.26% 79
2019
Q4 		$1.64M Sell
22,158
-4,254
-16% -$299K 0.33% 59
2019
Q3 		$1.71M Buy
26,412
+892
+3% +$52.9K 0.4% 53
2019
Q2 		$1.39M Sell
25,520
-880
-3% -$47.4K 0.33% 59
2019
Q1 		$1.42M Buy
26,400
+3,147
+14% +$194K 0.33% 56
2018
Q4 		$1.53M Sell
23,253
-1,329
-5% -$99.2K 0.39% 50
2018
Q3 		$1.94M Sell
24,582
-3,442
-12% -$246K 0.48% 46
2018
Q2 		$1.8M Sell
28,024
-593
-2% -$39.1K 0.54% 48
2018
Q1 		$1.78M Sell
28,617
-1,475
-5% -$106K 0.66% 43
2017
Q4 		$2.18M Sell
30,092
-6,098
-17% -$443K 0.81% 38
2017
Q3 		$2.94M Sell
36,190
-20,485
-36% -$1.62M 0.95% 29
2017
Q2 		$4.56M Sell
56,675
-3,322
-6% -$262K 0.99% 25
2017
Q1 		$4.71M Buy
59,997
+798
+1% +$63.7K 1% 25
2016
Q4 		$4.8M Buy
59,199
+4,423
+8% +$358K 1.05% 25
2016
Q3 		$4.87M Buy
54,776
+883
+2% +$83.3K 1.25% 16
2016
Q2 		$5.16M Buy
53,893
+6,388
+13% +$637K 1.37% 14
2016
Q1 		$5.42M Hold
47,505
– – 1.69% 14
2015
Q4 		$4.64M Buy
47,505
+12,108
+34% +$1.19M 1.28% 16
2015
Q3 		$3.42M Sell
35,397
-1,225
-3% -$129K 1.01% 18
2015
Q2 		$3.84M Buy
36,622
+451
+1% +$46.1K 1.01% 17
2015
Q1 		$3.73M Buy
36,171
+74
+0.2% +$7.49K 1.02% 17
2014
Q4 		$3.48M Buy
36,097
+166
+0.5% +$14.6K 1.04% 18
2014
Q3 		$2.86M Buy
35,931
+883
+3% +$69.6K 0.85% 29
2014
Q2 		$2.64M Buy
35,048
+1,367
+4% +$103K 0.75% 39
2014
Q1 		$2.52M Buy
33,681
+81
+0.2% +$5.72K 1.39% 23
2013
Q4 		$2.4M Buy
+33,600
New +$2.16M 1.33% 28

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Perigon Wealth Management's CVS Position: Q1 2026 in Review

Perigon Wealth Management reduced its CVS Health (CVS) stake by 2.6% in Q1 2026, selling an estimated $68.9K and leaving 32,994 shares worth $2.37M. The position accounts for 0.04% of the portfolio, ranked #340.

Perigon Wealth Management first reported a position in CVS in Q4 2013 and has held it in 50 quarters since. The position peaked at $5.42M in Q1 2016. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Perigon Wealth Management held 32,994 shares of CVS Health worth $2.37M as of Q1 2026.
  • Perigon Wealth Management sold 894 CVS Health shares in Q1 2026, an estimated $68.9K.
  • CVS Health made up 0.04% of Perigon Wealth Management's portfolio in Q1 2026, its #340 holding.
  • Perigon Wealth Management first reported a position in CVS Health in Q4 2013 and has held it in 50 quarters since.
  • Perigon Wealth Management's CVS Health position peaked at $5.42M in Q1 2016.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.